Robot Assisted MRI-Guided LITT of the Anterior, Lateral, and Medial Temporal Lobe for Temporal Lobe Epilepsy.
LITT (laser interstitial thermal therapy)
ROSA (robotized stereotactic assistant)
SEEG (stereoelectroencephalography)
temporal lobe epilepsy
temporal lobectomy
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
06
2020
accepted:
12
10
2020
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
18
12
2020
Statut:
epublish
Résumé
Robotic systems have fundamentally altered the landscape of functional neurosurgery. These allow automated stereotaxy with high accuracy and reliability, and are rapidly becoming a mainstay in stereotactic surgeries such as deep brain stimulation (DBS), stereoelectroencephalography (SEEG), and stereotactic laser ablation/MRI guided laser interstitial thermal therapy (MRgLITT). Robotic systems have been effectively applied to create a minimally invasive approach for diagnostics and therapeutics in the treatment of epilepsy, utilizing robots for expeditious and accurate stereotaxy for SEEG and MRgLITT. MRgLITT has been shown to approach open surgical techniques in efficacy of seizure control while minimizing collateral injury. We describe the use of robot assisted MRgLITT for a minimally invasive laser anterior temporal lobotomy, describing the approach and potential pitfalls. Goals of MRgLITT are complete ablation of the epileptogenic zone and avoiding injury to uninvolved structures. In the middle fossa these include structures such as cranial nerves in the skull base and cavernous sinus and the thalamus. These can be mitigated with careful trajectory planning and control of laser ablation intensity.
Identifiants
pubmed: 33329314
doi: 10.3389/fneur.2020.572334
pmc: PMC7729070
doi:
Types de publication
Journal Article
Langues
eng
Pagination
572334Informations de copyright
Copyright © 2020 Gupta, Dickey, Hu, Faught and Willie.
Déclaration de conflit d'intérêts
JW: Medtronic-consulting, research contract (SLATE trial), honoraria for teaching, Neuropace-consulting, research contract, honoraria for teaching, Clearpoint Neuro/MRI Interventions-consulting, AiM Medical-consulting. EF has received research support from UCB Pharma, Xenon, Eisai, and the NINDS, and consulting fees from Biogen, Supernus, SKLife Science, and the CDC. RH is involved with the Medtronic SLATE trial but receives no financial support. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neurosurg Focus. 2016 Oct;41(4):E5
pubmed: 27690660
Epilepsia. 2017 Jun;58(6):921-932
pubmed: 28261785
Stereotact Funct Neurosurg. 2019;97(4):255-265
pubmed: 31618749
Oper Neurosurg (Hagerstown). 2019 Jul 1;17(1):70-78
pubmed: 30339204
J Neurosurg. 2008 Mar;108(3):517-24
pubmed: 18312099
Brain. 2018 Jan 1;141(1):117-131
pubmed: 29253102
Stereotact Funct Neurosurg. 2018;96(5):327-334
pubmed: 30481770
Stereotact Funct Neurosurg. 2019;97(5-6):347-355
pubmed: 31935727
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Epilepsia. 2016 Apr;57(4):605-11
pubmed: 26864971
Epilepsia. 2019 Jun;60(6):1171-1183
pubmed: 31112302
J Neurosurg Pediatr. 2017 Oct;20(4):364-370
pubmed: 28777037
World Neurosurg. 2017 Aug;104:831-840
pubmed: 28454992
Epilepsia. 2020 Aug;61(8):1723-1734
pubmed: 32777090
N Engl J Med. 2001 Aug 2;345(5):311-8
pubmed: 11484687
Neurology. 2013 Apr 30;80(18):1669-76
pubmed: 23553475
Brain. 2004 Sep;127(Pt 9):2018-30
pubmed: 15215219
Epilepsia. 2015 Jan;56(1):101-13
pubmed: 25489630
World Neurosurg. 2017 Aug;104:467-475
pubmed: 28502693
Ann Neurol. 2018 Mar;83(3):575-587
pubmed: 29420840